Thoracic Tumours Register
ConditionThoracic Tumors
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
AgeNot listed
SponsorSpanish Lung Cancer Group
About this trial
Observational, multicenter study in patients with lung cancer and other thoracic tumors.
The GECP, in its commitment to improve the treatment and prognosis of patients with lung cancer and other thoracic tumors, has marked the individualization of treatment according to the expression of markers predictive of response to chemotherapeutic agents and molecular inhibitors of cell proliferation as one of its primary objectives. This could significantly improve the prognosis of patients with lung cancer, and will lead to a radical change in routine clinical practice. The aim of the register is to explore all data available of all patients treated because of thoracic tumours.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients with thoracic disease, treated with an active treatment or not treated (only palliative care)
Disqualifiers
Patients with other type of tumours
Trial population
All patients treated due to a thoracic tumour
Trial design
Design model
Other
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
10,000 Participants
are grouped into 5 trial groupsGroup A: Non-small cell lung cancer
Group B: Small cell lung cancer
Group C: Mesotelioma
Group D: timic cancer
Group E: carcinoid cancer
Trial outcomes
Primary outcomes
1
Describe epidemiology characteristics of lung cancer and other thoracic tumors in Spanish people
To know the epidemiology characteristics of lung cancer and other thoracic tumors in Spain, as well as clinical and histological data, diagnosis, treatments received, and prognostic factors
Time frame
up to 10 yearsSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov